| The ins and outs of lysophosphatidic acid signaling WH Moolenaar, LA van Meeteren, BNG Giepmans Bioessays 26 (8), 870-881, 2004 | 696 | 2004 |
| Autotaxin, a secreted lysophospholipase D, is essential for blood vessel formation during development LA Van Meeteren, P Ruurs, C Stortelers, P Bouwman, MA van Rooijen, ... Molecular and cellular biology, 2006 | 657 | 2006 |
| Vascular endothelial growth factor B controls endothelial fatty acid uptake CE Hagberg, A Falkevall, X Wang, E Larsson, J Huusko, I Nilsson, ... Nature 464 (7290), 917-921, 2010 | 575 | 2010 |
| Regulation and biological activities of the autotaxin–LPA axis LA Van Meeteren, WH Moolenaar Progress in lipid research 46 (2), 145-160, 2007 | 424 | 2007 |
| Regulation of endothelial cell plasticity by TGF-β LA van Meeteren, P Ten Dijke Cell and tissue research 347 (1), 177-186, 2012 | 415 | 2012 |
| Structural basis of substrate discrimination and integrin binding by autotaxin J Hausmann, S Kamtekar, E Christodoulou, JE Day, T Wu, Z Fulkerson, ... Nature structural & molecular biology 18 (2), 198-204, 2011 | 335 | 2011 |
| Inhibition of autotaxin by lysophosphatidic acid and sphingosine 1-phosphate LA Van Meeteren, P Ruurs, E Christodoulou, JW Goding, H Takakusa, ... Journal of Biological Chemistry 280 (22), 21155-21161, 2005 | 251 | 2005 |
| Boronic acid-based inhibitor of autotaxin reveals rapid turnover of LPA in the circulation HMHG Albers, A Dong, LA van Meeteren, DA Egan, M Sunkara, ... Proceedings of the National Academy of Sciences 107 (16), 7257-7262, 2010 | 243 | 2010 |
| Neuropilin-1 in regulation of VEGF-induced activation of p38MAPK and endothelial cell organization H Kawamura, X Li, K Goishi, LA van Meeteren, L Jakobsson, ... Blood, The Journal of the American Society of Hematology 112 (9), 3638-3649, 2008 | 207 | 2008 |
| Adipose-specific disruption of autotaxin enhances nutritional fattening and reduces plasma lysophosphatidic acid R Dusaulcy, C Rancoule, S Grès, E Wanecq, A Colom, C Guigné, ... Journal of lipid research 52 (6), 1247-1255, 2011 | 199 | 2011 |
| Autotaxin/lysopholipase D and lysophosphatidic acid regulate murine hemostasis and thrombosis Z Pamuklar, L Federico, S Liu, M Umezu-Goto, A Dong, M Panchatcharam, ... Journal of Biological Chemistry 284 (11), 7385-7394, 2009 | 184 | 2009 |
| Spider and bacterial sphingomyelinases D target cellular lysophosphatidic acid receptors by hydrolyzing lysophosphatidylcholine LA van Meeteren, F Frederiks, BNG Giepmans, MFF Pedrosa, ... Journal of Biological Chemistry 279 (12), 10833-10836, 2004 | 161 | 2004 |
| Fluorogenic phospholipid substrate to detect lysophospholipase D/autotaxin activity CG Ferguson, CS Bigman, RD Richardson, LA van Meeteren, ... Organic letters 8 (10), 2023-2026, 2006 | 143 | 2006 |
| Autotaxin (NPP-2) in the brain: cell type-specific expression and regulation during development and after neurotrauma NE Savaskan, L Rocha, MR Kotter, A Baer, G Lubec, LA Van Meeteren, ... Cellular and Molecular Life Sciences 64, 230-243, 2007 | 135 | 2007 |
| Synthesis, structure− activity relationships, and biological evaluation of fatty alcohol phosphates as lysophosphatidic acid receptor ligands, activators of PPARγ, and … GG Durgam, T Virag, MD Walker, R Tsukahara, S Yasuda, K Liliom, ... Journal of medicinal chemistry 48 (15), 4919-4930, 2005 | 134 | 2005 |
| Discovery and optimization of boronic acid based inhibitors of autotaxin HMHG Albers, LA van Meeteren, DA Egan, EW van Tilburg, ... Journal of medicinal chemistry 53 (13), 4958-4967, 2010 | 118 | 2010 |
| Anti-human activin receptor-like kinase 1 (ALK1) antibody attenuates bone morphogenetic protein 9 (BMP9)-induced ALK1 signaling and interferes with endothelial cell sprouting LA van Meeteren, M Thorikay, S Bergqvist, E Pardali, CG Stampino, ... Journal of Biological Chemistry 287 (22), 18551-18561, 2012 | 116 | 2012 |
| NRP1 presented in trans to the endothelium arrests VEGFR2 endocytosis, preventing angiogenic signaling and tumor initiation S Koch, LA van Meeteren, E Morin, C Testini, S Weström, H Björkelund, ... Developmental cell 28 (6), 633-646, 2014 | 113 | 2014 |
| TGF-β receptor signaling pathways in angiogenesis; emerging targets for anti-angiogenesis therapy L A van Meeteren, MJ Goumans, P ten Dijke Current pharmaceutical biotechnology 12 (12), 2108-2120, 2011 | 91 | 2011 |
| ENDOGLIN is dispensable for vasculogenesis, but required for vascular endothelial growth factor-induced angiogenesis Z Liu, F Lebrin, JA Maring, S van den Driesche, S van der Brink, ... PloS one 9 (1), e86273, 2014 | 90 | 2014 |
Lena Claesson-WelshUppsala UniversityVerified email at igp.uu.se